Regenerx Biopharmaceuticals inc   (RGRX)
Other Ticker:  
Price: $0.1050 $0.00 -2.326%
Day's High: $0.127 Week Perf: -6.08 %
Day's Low: $ 0.11 30 Day Perf: -20.21 %
Volume (M): 68 52 Wk High: $ 0.25
Volume (M$): $ 7 52 Wk Avg: $0.16
Open: $0.11 52 Wk Low: $0.10

 Market Capitalization (Millions $) 15
 Shares Outstanding (Millions) 144
 Employees -
 Revenues (TTM) (Millions $) 0
 Net Income (TTM) (Millions $) -2
 Cash Flow (TTM) (Millions $) -1
 Capital Exp. (TTM) (Millions $) 0

Regenerx Biopharmaceuticals Inc

   Company Address: 15245 Shady Grove Road ? Suite 470 Rockville 20850 MD
   Company Phone Number: 208-9191   Stock Exchange / Ticker: RGRX
   RGRX is expected to report next financial results on May 15, 2023.


Stock Performances by Major Competitors

5 Days Decrease / Increase
• View Complete Report

Talaris Therapeutics Inc

Talaris Therapeutics Inc announced operating shortfall of $-19.825 millions, in the most recent fiscal period

The stockholders have not hoped for any adjustments at the revenue during the the earnings season of the October to December 31 2022 at the Talaris Therapeutics Inc . Yet, they consider the Biotechnology & Pharmaceuticals company's operating shortfall which has been at $-19.825 millions, in the same period.

Inhibikase Therapeutics Inc

The company reported that Sales have truly advanced, amid the fiscal fourth quarter of 2022

For the fourth quarter of 2022 Inhibikase Therapeutics Inc decreased a loss per share of $-0.17 per share compare to $-0.20 a year ago and EPS improved from $-0.18 per share from the prior reporting season.

Sales grew sharply to $0.06 millions from $0.00 millions in the similar reporting season a year ago and sequentially Sales doubled by 771.842 % from $0.01 millions.

Scynexis Inc

Scynexis Inc reported exceptional results, amid the October to December 31 2022 interval

For the most recent fiscal period SCYX decreased a loss per share of $-0.22 per share compare to $-1.08 a year ago and earnings per share improved from $-0.62 per share from the preceding reporting period.

Sales increased sharply by 155.276 % to $1.52 millions from $0.60 millions in the comparable reporting period a year ago and sequentially Sales decreased by -2.119 % from $1.56 millions.

Disc Medicine Inc

Business expenditures were increasing at the IRON in the financial fourth quarter of 2022

Trailing the big players in the Major Pharmaceutical Preparations sector, a number of overlooked businesses are impending with their numbers. IRON said it has realized operating loss of $-21.327 millions, for the fourth quarter of 2022.

Lm Funding America Inc

The Deficit has expanded at the Miscellaneous Financial Services company all along the financial time-frame closing December 31 2022

Lm Funding America Inc announced very solid Sales rise of 692.169 % year on year to $1.12 millions in the financial span closing Dec 31 2022, but increased a deficit per share at $-0.95.


Regenerx Biopharmaceuticals Inc 's Segments
• View Complete Report


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production


Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales


Event Calendar

PLCE's Profile

Stock Price

PLCE's Financials

Business Description


Charts & Quotes

PLCE's News


PLCE's Competitors

Customers & Markets

Economic Indicators

PLCE's Growth

Company Segments


Stock Performance

Growth Rates




Financial Strength


Largest Companies

Management Effectivness


At a Glance


Growth Rates



Financial Strength


At a Glance



Sectors & Industries




At a Glance








About us


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071